1. Home
  2. MTSI vs INM Comparison

MTSI vs INM Comparison

Compare MTSI & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSI
  • INM
  • Stock Information
  • Founded
  • MTSI 1950
  • INM 1981
  • Country
  • MTSI United States
  • INM Canada
  • Employees
  • MTSI N/A
  • INM N/A
  • Industry
  • MTSI Semiconductors
  • INM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTSI Technology
  • INM Health Care
  • Exchange
  • MTSI Nasdaq
  • INM Nasdaq
  • Market Cap
  • MTSI N/A
  • INM 2.5M
  • IPO Year
  • MTSI 2012
  • INM N/A
  • Fundamental
  • Price
  • MTSI $101.39
  • INM $0.27
  • Analyst Decision
  • MTSI Strong Buy
  • INM
  • Analyst Count
  • MTSI 9
  • INM 0
  • Target Price
  • MTSI $118.33
  • INM N/A
  • AVG Volume (30 Days)
  • MTSI 442.0K
  • INM 19.2M
  • Earning Date
  • MTSI 11-07-2024
  • INM 11-12-2024
  • Dividend Yield
  • MTSI N/A
  • INM N/A
  • EPS Growth
  • MTSI N/A
  • INM N/A
  • EPS
  • MTSI 0.99
  • INM N/A
  • Revenue
  • MTSI $679,243,000.00
  • INM $5,625,728.00
  • Revenue This Year
  • MTSI $14.69
  • INM N/A
  • Revenue Next Year
  • MTSI $18.49
  • INM N/A
  • P/E Ratio
  • MTSI $102.68
  • INM N/A
  • Revenue Growth
  • MTSI 0.45
  • INM 140.49
  • 52 Week Low
  • MTSI $68.58
  • INM $0.12
  • 52 Week High
  • MTSI $118.77
  • INM $2.08
  • Technical
  • Relative Strength Index (RSI)
  • MTSI 50.28
  • INM 47.82
  • Support Level
  • MTSI $95.03
  • INM $0.26
  • Resistance Level
  • MTSI $103.51
  • INM $0.34
  • Average True Range (ATR)
  • MTSI 3.73
  • INM 0.05
  • MACD
  • MTSI -0.16
  • INM -0.01
  • Stochastic Oscillator
  • MTSI 48.33
  • INM 9.09

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: